Document is current
Any future updates will be listed below
-
Authors
Chien, Shih-Chieh
Lan, Wei-Ren
Yun, Chun-Ho
Sung, Kuo-Tzu
Yeh, Hung-I
Tsai, Cheng-Ting
Chien, Chen-Yen
Hung, Chung-Lieh
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195-020–MY1, MOST 103-2314-B-195-006-MY3, NSC102-2314-B-002-046-MY3, 106-2314-B-195-008-MY2, 108-2314-B-195-018-MY2, MOST 108-2314-B-195-018-MY2, MOST 109-2314-B-715-008, and MOST 110-2314-B-715-009-MY1)
Mackay Memorial Hospital (10271, 10248, 10220, 10253, 10375, 10358, and E-102003)
Taiwan Foundation for geriatric emergency and critical care
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 21 October 2024
First Online: 26 October 2024
Change Date: 3 July 2026
Change Type: Update
Change Details: The original online version of this Article was revised: The original version of this Article omitted an affiliation for Chen-Yen Chien. The correct affiliations are: ‘Division of Cardiovascular Surgery, Department of Surgery, MacKay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Taipei 10449, Taiwan.’ and ‘Department of Medicine, Mackay Medical College, No.46, Sec. 3, Zhongzheng Rd., Sanzhi Dist., New Taipei City, Taiwan.’ The original Article has been corrected.
Declarations
Competing interests: Declaration of competing interest. Dr. CLH declares honoraria for lectures, presentations as speakers with AstraZeneca, Boehringer Ingelheim, Sanofi and Bayer Pharma. Dr. Hung-I Yeh has received honorarium from AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, MSD, Novartis, Novo Nordisk, Pfizer, and Sanofi. All other authors declare no conflicts of interest.
